Search Count: 14
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-12-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTM |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-12-07
Ligands: XTM
 |
Crystallization Of Feline Coronavirus Mpro With Gc376 Reveals Mechanism Of Inhibition
Organism: Feline coronavirus
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2022-04-06 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: UED |
Organism: Feline coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2022-04-06
Ligands: UED
 |
Crystallization Of Feline Coronavirus Mpro With Gc376 Reveals Mechanism Of Inhibition
Organism: Feline coronavirus
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2022-04-06 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: UED |
Organism: Feline coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2022-04-06
Ligands: UED
 |
Peptidomimetic Nitrile Warheads As Sars-Cov-2 3Cl Protease Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-09-01 Classification: VIRAL PROTEIN Ligands: 4IT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-09-01
Ligands: 4IT
 |
Structure Of Sars-Cov2 3Cl Protease Covalently Bound To Peptidomimetic Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-07-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: YWJ, FN7 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: YWJ, FN7
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTJ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XTJ
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTP |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XTP
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XU4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XU4
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XV4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XV4
 |
N-Terminal Finger Stabilizes Feline Drug Gc376 In Coronavirus 3Cl Protease
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: UED, EDO, CA |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-05-12
Ligands: UED, EDO, CA
 |
N-Terminal Finger Stabilizes Feline Drug Gc376 In Coronavirus 3Cl Protease
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: EDO, UED |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-05-12
Ligands: EDO, UED
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: K36 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: K36
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: UED |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: UED
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20